Knight Therapeutics | GUD - EPS Earnings Per Share



Knight Therapeutics reported CAD0 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.


Fiscal Calendar Actual Consensus Previous Date
-0.13 0.02 -0.23 Aug/07 2025
-0.23 -0.01 -0.13 Mar/21 2024
FY2023Q3 Sep/2023 0.09 -0.03 0.01 Nov/09 2023
FY2023Q2 Jun/2023 0.02 0.01 0.02 Aug/10 2023
FY2023Q1 Mar/2023 -0.04 -0.06 -0.16 May/11 2023
FY2022Q4 Dec/2022 -0.13 -0.07 Mar/23 2023
FY2022Q3 Sep/2022 0.01 -0.05 -0.07 Nov/10 2022
FY2022Q2 Jun/2022 0.02 -0.03 0.23 Aug/11 2022
FY2022Q1 Mar/2022 -0.16 -0.04 0.03 May/12 2022
FY2021Q4 Dec/2021 -0.07 0.06 Mar/24 2022
FY2021Q3 Sep/2021 -0.07 0.02 0.14 Nov/11 2021
FY2021Q2 Jun/2021 0.23 -0.08 0.13 Aug/13 2021


Eps Change Date
Acasti Pharma CAD -0.21 0.15 Jun/2025
Alaunos Therapeutics USD -0.46 0.24 Dec/2024
Aurora Cannabis CAD -0.26 0.84 Jun/2025
Avita Medical USD -0.21 0.05 Dec/2024
Canopy Growth CAD -0.22 0.89 Jun/2025
Cronos Group USD -0.1 0.12 Jun/2025
Dianthus Therapeutics USD -0.88 0.07 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
IQVIA Holdings USD 2.81 0.11 Jun/2025
Knight Therapeutics CAD 0 0.02 Sep/2024
Moderna USD -2.13 0.39 Jun/2025
Organigram Holdings CAD -0.05 0.16 Jun/2025
Organon & Co USD 1 0.02 Jun/2025
Revvity USD 1.18 0.17 Jun/2025
Tectonic Therapeutic USD -1.07 0.23 Jun/2025
Tilray USD -1.78 0.54 Jun/2025
Viatris USD 0.62 0.12 Jun/2025
Xeris Pharmaceuticals USD -0.01 0.02 Jun/2025